Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis [2]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 3, 2008, Pages 364-365

  Dauendorffer, J N ^a   Mahé, Emmanuel ^a   Saiag, P ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; DAPSONE; FUSIDIC ACID; JOSAMYCIN; TACROLIMUS;

ADJUVANT THERAPY; ANAMNESIS; ATOPIC DERMATITIS; BULLOUS SKIN DISEASE; CASE REPORT; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMPETIGO; LETTER; LINEAR IMMUNOGLOBULIN A BULLOUS DERMATOSIS; LOW DRUG DOSE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SKIN BIOPSY; SKIN EXAMINATION;

ADMINISTRATION, TOPICAL; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; DAPSONE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OINTMENTS; SKIN DISEASES; TACROLIMUS;

EID: 39049104970     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02315.x     Document Type: Letter

References (5)

1. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719-727.
2. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000; 25: 250-254.
3. Chu J, Bradley M, Marinkovich MP. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. Arch Dermatol 2003; 139: 813-815.
4. Günther C, Wozel G, Meurer M, Pfieffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol 2004; 50: 325-326.
5. Caproni M, Rolfo S, Bernacchi E, Bianchi B, Brazzini B, Fabbri P. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis. Br J Dermatol 1999; 140: 1072-1078.